{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T22:51:46Z","timestamp":1789858306167,"version":"4.0.1"},"reference-count":101,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2024,5,30]],"date-time":"2024-05-30T00:00:00Z","timestamp":1717027200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,5,30]],"date-time":"2024-05-30T00:00:00Z","timestamp":1717027200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurochem Res"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1007\/s11064-024-04158-0","type":"journal-article","created":{"date-parts":[[2024,5,30]],"date-time":"2024-05-30T09:00:50Z","timestamp":1717059650000},"page":"2038-2059","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Effect of Capsaicin on 3-NP-Induced Neurotoxicity: A Pre-Clinical Study"],"prefix":"10.1007","volume":"49","author":[{"given":"Sakshi","family":"Tyagi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1187-602X","authenticated-orcid":false,"given":"Ajit Kumar","family":"Thakur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,5,30]]},"reference":[{"key":"4158_CR1","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1602\/neurorx.1.1.128","volume":"1","author":"J Leegwater-Kim","year":"2004","unstructured":"Leegwater-Kim J, Cha JH (2004) The paradigm of Huntington\u2019s disease: therapeutic opportunities in neurodegeneration. NeuroRx 1:128\u2013138","journal-title":"NeuroRx"},{"key":"4158_CR2","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.1002\/mds.21971","volume":"23","author":"W Phillips","year":"2008","unstructured":"Phillips W, Shannon KM, Barker RA (2008) The current clinical management of Huntington\u2019s disease. Mov Disord 23:1491\u20131504","journal-title":"Mov Disord"},{"key":"4158_CR3","first-page":"16","volume":"59","author":"DC Rubinsztein","year":"1996","unstructured":"Rubinsztein DC, Leggo J, Coles R, Almqvist E, Biancalana V, Cassiman JJ, Chotai K, Connarty M, Crauford D, Curtis A, Curtis D, Davidson MJ, Differ AM, Dode C, Dodge A, Frontali M, Ranen NG, Stine OC, Sherr M, Abbott MH, Franz ML, Graham CA, Harper PS, Hedreen JC, Hayden MR et al (1996) Phenotypic characterization of individuals with 30\u201340 CAG repeats in the Huntington disease (HD) gene reveals HD cases with 36 repeats and apparently normal elderly individuals with 36\u201339 repeats. Am J Hum Genet 59:16\u201322","journal-title":"Am J Hum Genet"},{"key":"4158_CR4","doi-asserted-by":"publisher","first-page":"10116","DOI":"10.1523\/JNEUROSCI.18-23-10116.1998","volume":"18","author":"DS Reynolds","year":"1998","unstructured":"Reynolds DS, Carter RJ, Morton AJ (1998) Dopamine modulates the susceptibility of striatal neurons to 3-nitropropionic acid in the rat model of Huntington\u2019s disease. J Neurosci 18:10116\u201310127","journal-title":"J Neurosci"},{"key":"4158_CR5","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.brainresbull.2005.06.024","volume":"67","author":"M Tariq","year":"2005","unstructured":"Tariq M, Khan HA, Elfaki I, Al Deeb S, Al Moutaery K (2005) Neuroprotective effect of nicotine against 3-nitropropionic acid (3-NP)-induced experimental Huntington\u2019s disease in rats. Brain Res Bull 67:161\u2013168","journal-title":"Brain Res Bull"},{"key":"4158_CR6","doi-asserted-by":"publisher","first-page":"878","DOI":"10.3390\/molecules15020878","volume":"15","author":"I T\u00fanez","year":"2010","unstructured":"T\u00fanez I, Tasset I, P\u00e9rez-De La Cruz V, Santamar\u00eda A (2010) 3-Nitropropionic acid as a tool to study the mechanisms involved in Huntington\u2019s disease: past, present and future. Molecules 15:878\u2013916","journal-title":"Molecules"},{"key":"4158_CR7","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.tox.2007.11.003","volume":"244","author":"M Ahuja","year":"2008","unstructured":"Ahuja M, Bishnoi M, Chopra K (2008) Protective effect of minocycline, a semi-synthetic second-generation tetracycline against 3-nitropropionic acid (3-NP)-induced neurotoxicity. Toxicology 244:111\u2013122","journal-title":"Toxicology"},{"key":"4158_CR8","doi-asserted-by":"publisher","first-page":"3919","DOI":"10.1093\/hmg\/ddq306","volume":"19","author":"J Kim","year":"2010","unstructured":"Kim J, Moody JP, Edgerly CK, Bordiuk OL, Cormier K, Smith K, Beal MF, Ferrante RJ (2010) Mitochondrial loss, dysfunction and altered dynamics in Huntington\u2019s disease. Hum Mol Genet 19:3919\u20133935","journal-title":"Hum Mol Genet"},{"key":"4158_CR9","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/S0304-3940(97)00482-5","volume":"231","author":"M Kodsi","year":"1997","unstructured":"Kodsi M, Swerdlow N (1997) Mitochondrial toxin 3-nitropropionic acid produces startle reflex abnormalities and striatal damage in rats that model some features of Huntington\u2019s disease. Neurosci Lett 231:103\u2013107","journal-title":"Neurosci Lett"},{"key":"4158_CR10","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1016\/j.neures.2009.01.005","volume":"63","author":"P Kumar","year":"2009","unstructured":"Kumar P, Kumar A (2009) Neuroprotective effect of cyclosporine and FK506 against 3-nitropropionic acid induced cognitive dysfunction and glutathione redox in rat: possible role of nitric oxide. Neurosci Res 63:302\u2013314","journal-title":"Neurosci Res"},{"key":"4158_CR11","doi-asserted-by":"publisher","first-page":"41","DOI":"10.5214\/ans.0972.7531.2006.130204","volume":"13","author":"P Kumar","year":"2006","unstructured":"Kumar P, Padi SS, Naidu P, Kumar A (2006) Protective effect of antioxidants on 3-nitropropionic acid induced oxidative stress and cognitive impairment. Ann Neurosci 13:41\u201347","journal-title":"Ann Neurosci"},{"key":"4158_CR12","doi-asserted-by":"publisher","first-page":"S33","DOI":"10.1002\/gps.933","volume":"18","author":"S Bleich","year":"2003","unstructured":"Bleich S, Romer K, Wiltfang J, Kornhuber J (2003) Glutamate and the glutamate receptor system: a target for drug action. Int J Geriatr Psychiatry 18:S33\u201340","journal-title":"Int J Geriatr Psychiatry"},{"key":"4158_CR13","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1196\/annals.1300.002","volume":"1003","author":"PJ Conn","year":"2003","unstructured":"Conn PJ (2003) Physiological roles and therapeutic potential of metabotropic glutamate receptors. Ann N Y Acad Sci 1003:12\u201321","journal-title":"Ann N Y Acad Sci"},{"key":"4158_CR14","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1146\/annurev.ne.13.030190.001131","volume":"13","author":"DW Choi","year":"1990","unstructured":"Choi DW, Rothman SM (1990) The role of glutamate neurotoxicity in hypoxic-ischemic neuronal death. Annu Rev Neurosci 13:171\u2013182","journal-title":"Annu Rev Neurosci"},{"key":"4158_CR15","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/0166-2236(87)90177-9","volume":"10","author":"SM R","year":"1987","unstructured":"SM R (1987) Excitotoxicity and the NMDA receptor. Trends Neurosci 10:299\u2013302","journal-title":"Trends Neurosci"},{"key":"4158_CR16","doi-asserted-by":"publisher","first-page":"4391","DOI":"10.3390\/ijms20184391","volume":"20","author":"Z Zhang","year":"2019","unstructured":"Zhang Z, Zhang S, Fu P, Zhang Z, Lin K, Ko JK, Yung KK (2019) Roles of glutamate receptors in Parkinson\u2019s Disease. Int J Mol Sci 20:4391","journal-title":"Int J Mol Sci"},{"key":"4158_CR17","doi-asserted-by":"publisher","first-page":"7452","DOI":"10.3390\/ijms21207452","volume":"21","author":"VN Bukke","year":"2020","unstructured":"Bukke VN, Archana M, Villani R, Romano AD, Wawrzyniak A, Balawender K, Orkisz S, Beggiato S, Serviddio G, Cassano T (2020) The dual role of glutamatergic neurotransmission in Alzheimer\u2019s Disease: from pathophysiology to Pharmacotherapy. Int J Mol Sci 21:7452","journal-title":"Int J Mol Sci"},{"key":"4158_CR18","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1111\/jnc.14723","volume":"150","author":"AI Smith-Dijak","year":"2019","unstructured":"Smith-Dijak AI, Sepers MD, Raymond LA (2019) Alterations in synaptic function and plasticity in Huntington disease. J Neurochem 150:346\u2013365","journal-title":"J Neurochem"},{"key":"4158_CR19","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.neuint.2015.10.011","volume":"95","author":"M Venigalla","year":"2016","unstructured":"Venigalla M, Sonego S, Gyengesi E, Sharman MJ, Munch G (2016) Novel promising therapeutics against chronic neuroinflammation and neurodegeneration in Alzheimer\u2019s disease. Neurochem Int 95:63\u201374","journal-title":"Neurochem Int"},{"key":"4158_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40035-015-0042-0","volume":"4","author":"Q Wang","year":"2015","unstructured":"Wang Q, Liu Y, Zhou J (2015) Neuroinflammation in Parkinson\u2019s disease and its potential as therapeutic target. Transl Neurodegener 4:1\u20139","journal-title":"Transl Neurodegener"},{"key":"4158_CR21","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.2174\/1570159X19666211201094608","volume":"20","author":"J Saba","year":"2022","unstructured":"Saba J, Couselo FL, Bruno J, Carniglia L, Durand D, Lasaga M, Caruso C (2022) Neuroinflammation in Huntington\u2019s Disease: a Starring Role for Astrocyte and Microglia. Curr Neuropharmacol 20:1116\u20131143","journal-title":"Curr Neuropharmacol"},{"key":"4158_CR22","doi-asserted-by":"crossref","unstructured":"Perry VH, Teeling J (2013) Microglia and macrophages of the central nervous system: the contribution of microglia priming and systemic inflammation to chronic neurodegeneration. Seminars in immunopathology. Springer, pp 601\u2013612","DOI":"10.1007\/s00281-013-0382-8"},{"key":"4158_CR23","doi-asserted-by":"publisher","first-page":"193","DOI":"10.3389\/fnagi.2017.00193","volume":"9","author":"HM Yang","year":"2017","unstructured":"Yang HM, Yang S, Huang SS, Tang BS, Guo JF (2017) Microglial activation in the Pathogenesis of Huntington\u2019s Disease. Front Aging Neurosci 9:193","journal-title":"Front Aging Neurosci"},{"key":"4158_CR24","doi-asserted-by":"publisher","first-page":"215","DOI":"10.3389\/fncel.2018.00215","volume":"12","author":"S Lively","year":"2018","unstructured":"Lively S, Schlichter LC (2018) Microglia responses to pro-inflammatory stimuli (LPS, IFNgamma\u2009+\u2009TNFalpha) and reprogramming by resolving cytokines (IL-4, IL-10). Front Cell Neurosci 12:215","journal-title":"Front Cell Neurosci"},{"key":"4158_CR25","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1038\/s41593-018-0242-x","volume":"21","author":"S Hickman","year":"2018","unstructured":"Hickman S, Izzy S, Sen P, Morsett L, El Khoury J (2018) Microglia in neurodegeneration. Nat Neurosci 21:1359\u20131369","journal-title":"Nat Neurosci"},{"key":"4158_CR26","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.brainresbull.2011.10.004","volume":"87","author":"JA Smith","year":"2012","unstructured":"Smith JA, Das A, Ray SK, Banik NL (2012) Role of pro-inflammatory cytokines released from microglia in neurodegenerative diseases. Brain Res Bull 87:10\u201320","journal-title":"Brain Res Bull"},{"key":"4158_CR27","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1016\/j.nurt.2010.05.014","volume":"7","author":"ME Lull","year":"2010","unstructured":"Lull ME, Block ML (2010) Microglial activation and chronic neurodegeneration. Neurotherapeutics 7:354\u2013365","journal-title":"Neurotherapeutics"},{"key":"4158_CR28","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1111\/jnc.15171","volume":"156","author":"YF Zheng","year":"2021","unstructured":"Zheng YF, Zhou X, Chang D, Bhuyan DJ, Zhang JP, Yu WZ, Jiang XS, Seto SW, Yeon SY, Li J, Li CG (2021) A novel tri-culture model for neuroinflammation. J Neurochem 156:249\u2013261","journal-title":"J Neurochem"},{"key":"4158_CR29","doi-asserted-by":"publisher","first-page":"1826","DOI":"10.1093\/hmg\/ddt036","volume":"22","author":"HY Hsiao","year":"2013","unstructured":"Hsiao HY, Chen YC, Chen HM, Tu PH, Chern Y (2013) A critical role of astrocyte-mediated nuclear factor-kappab-dependent inflammation in Huntington\u2019s disease. Hum Mol Genet 22:1826\u20131842","journal-title":"Hum Mol Genet"},{"key":"4158_CR30","doi-asserted-by":"publisher","first-page":"2980","DOI":"10.3390\/ijerph8072980","volume":"8","author":"AD Kraft","year":"2011","unstructured":"Kraft AD, Harry GJ (2011) Features of microglia and neuroinflammation relevant to environmental exposure and neurotoxicity. Int J Environ Res Public Health 8:2980\u20133018","journal-title":"Int J Environ Res Public Health"},{"key":"4158_CR31","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1111\/j.1755-5949.2010.00209.x","volume":"17","author":"J Demeestere","year":"2011","unstructured":"Demeestere J, Vandenberghe W (2011) Experimental surgical therapies for Huntington\u2019s disease. CNS Neurosci Ther 17:705\u2013713","journal-title":"CNS Neurosci Ther"},{"key":"4158_CR32","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1007\/s00401-021-02292-5","volume":"141","author":"ES Pinarbasi","year":"2021","unstructured":"Pinarbasi ES, Liu EA, Yu Z, Kopyov O, Brown NA, Dayalu P, Lieberman AP (2021) Donor-containing cortical and intraventricular glioneuronal nodules in Huntington\u2019s disease brain decades after fetal cell transplantation. Acta Neuropathol 141:979\u2013981","journal-title":"Acta Neuropathol"},{"key":"4158_CR33","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.nurt.2008.01.008","volume":"5","author":"OR Adam","year":"2008","unstructured":"Adam OR, Jankovic J (2008) Symptomatic treatment of Huntington disease. Neurotherapeutics 5:181\u2013197","journal-title":"Neurotherapeutics"},{"key":"4158_CR34","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1097\/WCO.0b013e328304b692","volume":"21","author":"E Roze","year":"2008","unstructured":"Roze E, Saudou F, Caboche J (2008) Pathophysiology of Huntington\u2019s disease: from huntingtin functions to potential treatments. Curr Opin Neurol 21:497\u2013503","journal-title":"Curr Opin Neurol"},{"key":"4158_CR35","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1042\/BJ20071619","volume":"412","author":"S Imarisio","year":"2008","unstructured":"Imarisio S, Carmichael J, Korolchuk V, Chen CW, Saiki S, Rose C, Krishna G, Davies JE, Ttofi E, Underwood BR, Rubinsztein DC (2008) Huntington\u2019s disease: from pathology and genetics to potential therapies. Biochem J 412:191\u2013209","journal-title":"Biochem J"},{"key":"4158_CR36","first-page":"68","volume":"30","author":"S Tyagi","year":"2024","unstructured":"Tyagi S, Shekhar N, Thakur AK (2024) Alternative approaches for the management of Huntington\u2019s Disease: a narrative review. Altern Ther Health Med 30:68\u201375","journal-title":"Altern Ther Health Med"},{"key":"4158_CR37","doi-asserted-by":"publisher","first-page":"657","DOI":"10.2147\/NDT.S6430","volume":"6","author":"S Frank","year":"2010","unstructured":"Frank S (2010) Tetrabenazine: the first approved drug for the treatment of chorea in US patients with Huntington disease. Neuropsychiatr Dis Treat 6:657\u2013665","journal-title":"Neuropsychiatr Dis Treat"},{"key":"4158_CR38","doi-asserted-by":"publisher","first-page":"466","DOI":"10.3109\/01480545.2013.776583","volume":"36","author":"BD Shivasharan","year":"2013","unstructured":"Shivasharan BD, Nagakannan P, Thippeswamy BS, Veerapur VP, Bansal P, Unnikrishnan MK (2013) Protective effect of Calendula officinalis Linn. Flowers against 3-nitropropionic acid induced experimental Huntington\u2019s disease in rats. Drug Chem Toxicol 36:466\u2013473","journal-title":"Drug Chem Toxicol"},{"key":"4158_CR39","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.jep.2012.01.012","volume":"140","author":"P Nagakannan","year":"2012","unstructured":"Nagakannan P, Shivasharan BD, Thippeswamy BS, Veerapur VP, Bansal P (2012) Protective effect of hydroalcoholic extract of Mimusops elengi Linn. Flowers against middle cerebral artery occlusion induced brain injury in rats. J Ethnopharmacol 140:247\u2013254","journal-title":"J Ethnopharmacol"},{"key":"4158_CR40","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1615\/JEnvironPatholToxicolOncol.v31.i3.30","volume":"31","author":"P Nagakannan","year":"2012","unstructured":"Nagakannan P, Shivasharan BD, Thippeswamy BS, Veerapur VP (2012) Restoration of brain antioxidant status by hydroalcoholic extract of Mimusops elengi flowers in rats treated with monosodium glutamate. J Environ Pathol Toxicol Oncol 31:213\u2013221","journal-title":"J Environ Pathol Toxicol Oncol"},{"key":"4158_CR41","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1007\/s12291-012-0256-1","volume":"28","author":"BD Shivasharan","year":"2013","unstructured":"Shivasharan BD, Nagakannan P, Thippeswamy BS, Veerapur VP (2013) Protective effect of Calendula officinalis L. flowers against Monosodium Glutamate Induced oxidative stress and excitotoxic brain damage in rats. Indian J Clin Biochem 28:292\u2013298","journal-title":"Indian J Clin Biochem"},{"key":"4158_CR42","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1007\/s12640-011-9258-7","volume":"20","author":"BS Thippeswamy","year":"2011","unstructured":"Thippeswamy BS, Nagakannan P, Shivasharan BD, Mahendran S, Veerapur VP, Badami S (2011) Protective effect of embelin from Embelia ribes Burm. Against transient global ischemia-induced brain damage in rats. Neurotox Res 20:379\u2013386","journal-title":"Neurotox Res"},{"key":"4158_CR43","doi-asserted-by":"publisher","first-page":"38","DOI":"10.2991\/efood.k.200203.001","volume":"1","author":"H Khan","year":"2020","unstructured":"Khan H, Ullah H, Tundis R, Belwal T, Devkota HP, Daglia M, Cetin Z, Saygili EI, Campos MG, Capanoglu E (2020) Dietary flavonoids in the management of Huntington\u2019s disease: mechanism and clinical perspective. EFood 1:38\u201352","journal-title":"EFood"},{"key":"4158_CR44","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.1007\/s11064-022-03549-5","volume":"47","author":"S Tyagi","year":"2022","unstructured":"Tyagi S, Shekhar N, Thakur AK (2022) Protective role of Capsaicin in Neurological disorders: an overview. Neurochem Res 47:1513\u20131531","journal-title":"Neurochem Res"},{"key":"4158_CR45","doi-asserted-by":"crossref","unstructured":"Tyagi S, Thakur AK (2024) Beneficial role of capsaicin through modulation of mitochondrial functions in MPTP-injected mice. Neurosci Behav Physiol :1\u201315","DOI":"10.1007\/s11055-024-01560-7"},{"key":"4158_CR46","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1038\/39807","volume":"389","author":"MJ Caterina","year":"1997","unstructured":"Caterina MJ, Schumacher MA, Tominaga M, Rosen TA, Levine JD, Julius D (1997) The capsaicin receptor: a heat-activated ion channel in the pain pathway. Nature 389:816\u2013824","journal-title":"Nature"},{"key":"4158_CR47","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1124\/pr.113.008268","volume":"66","author":"B Nilius","year":"2014","unstructured":"Nilius B, Szallasi A (2014) Transient receptor potential channels as drug targets: from the science of basic research to the art of medicine. Pharmacol Rev 66:676\u2013814","journal-title":"Pharmacol Rev"},{"key":"4158_CR48","doi-asserted-by":"publisher","first-page":"3655","DOI":"10.1073\/pnas.97.7.3655","volume":"97","author":"E Mezey","year":"2000","unstructured":"Mezey E, Toth ZE, Cortright DN, Arzubi MK, Krause JE, Elde R, Guo A, Blumberg PM, Szallasi A (2000) Distribution of mRNA for vanilloid receptor subtype 1 (VR1), and VR1-like immunoreactivity, in the central nervous system of the rat and human. Proc Natl Acad Sci U S A 97:3655\u20133660","journal-title":"Proc Natl Acad Sci U S A"},{"key":"4158_CR49","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.tins.2008.12.006","volume":"32","author":"JA Kauer","year":"2009","unstructured":"Kauer JA, Gibson HE (2009) Hot flash: TRPV channels in the brain. Trends Neurosci 32:215\u2013224","journal-title":"Trends Neurosci"},{"key":"4158_CR50","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1017\/S0317167100032212","volume":"18","author":"AC Ludolph","year":"1991","unstructured":"Ludolph AC, He F, Spencer PS, Hammerstad J, Sabri M (1991) 3-Nitropropionic acid-exogenous animal neurotoxin and possible human striatal toxin. Can J Neurol Sci 18:492\u2013498","journal-title":"Can J Neurol Sci"},{"key":"4158_CR51","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1002\/mds.21222","volume":"22","author":"C Kenney","year":"2007","unstructured":"Kenney C, Hunter C, Jankovic J (2007) Long-term tolerability of tetrabenazine in the treatment of hyperkinetic movement disorders. Mov Disord 22:193\u2013197","journal-title":"Mov Disord"},{"key":"4158_CR52","doi-asserted-by":"publisher","first-page":"146","DOI":"10.5472\/marumj.816319","volume":"33","author":"B Terz\u0131oglu Beb\u0131toglu","year":"2020","unstructured":"Terz\u0131oglu Beb\u0131toglu B, Oguz E, Acet NG, Hodz\u0131c A, Temel F, Ada S, K\u0131l\u0131ckap A (2020) The neuroprotective effect of lamotrigine against glutamate excitotoxicity in SH-SY5Y human neuroblastoma cells. Marmara Med J 33:146\u2013152","journal-title":"Marmara Med J"},{"key":"4158_CR53","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/0003-2697(79)90738-3","volume":"95","author":"H Ohkawa","year":"1979","unstructured":"Ohkawa H, Ohishi N, Yagi K (1979) Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 95:351\u2013358","journal-title":"Anal Biochem"},{"key":"4158_CR54","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1006\/nbdi.1999.0254","volume":"6","author":"JW Russell","year":"1999","unstructured":"Russell JW, Sullivan KA, Windebank AJ, Herrmann DN, Feldman EL (1999) Neurons undergo apoptosis in animal and cell culture models of diabetes. Neurobiol Dis 6:347\u2013363","journal-title":"Neurobiol Dis"},{"key":"4158_CR55","doi-asserted-by":"publisher","first-page":"1402","DOI":"10.3390\/molecules28031402","volume":"28","author":"WA Mahdi","year":"2023","unstructured":"Mahdi WA, AlGhamdi SA, Alghamdi AM, Imam SS, Alshehri S, Almaniea MA, Hajjar BM, Al-Abbasi FA, Sayyed N, Kazmi I (2023) Neuroprotectant effects of Hibiscetin in 3-Nitropropionic Acid-Induced Huntington\u2019s Disease via subsiding oxidative stress and modulating Monoamine neurotransmitters in rats Brain. Molecules 28:1402","journal-title":"Molecules"},{"key":"4158_CR56","doi-asserted-by":"publisher","first-page":"672","DOI":"10.3109\/15376516.2014.961216","volume":"24","author":"S Dhadde","year":"2014","unstructured":"Dhadde S, Durg S, Potadar P (2014) Piroxicam attenuates 3-nitropropionic acid-induced brain oxidative stress and behavioral alteration in mice. Toxicol Mech Methods 24:672\u2013678","journal-title":"Toxicol Mech Methods"},{"key":"4158_CR57","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.ejphar.2009.04.058","volume":"615","author":"P Kumar","year":"2009","unstructured":"Kumar P, Kumar A (2009) Protective effect of rivastigmine against 3-nitropropionic acid-induced Huntington\u2019s disease like symptoms: possible behavioural, biochemical and cellular alterations. Eur J Pharmacol 615:91\u2013101","journal-title":"Eur J Pharmacol"},{"key":"4158_CR58","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1007\/BF00177912","volume":"92","author":"RG Lister","year":"1987","unstructured":"Lister RG (1987) The use of a plus-maze to measure anxiety in the mouse. Psychopharmacology 92:180\u2013185","journal-title":"Psychopharmacology"},{"key":"4158_CR59","doi-asserted-by":"publisher","first-page":"331","DOI":"10.3389\/fnbeh.2014.00331","volume":"8","author":"S Sgroi","year":"2014","unstructured":"Sgroi S, Kaelin-Lang A, Capper-Loup C (2014) Spontaneous locomotor activity and L-DOPA-induced dyskinesia are not linked in 6-OHDA parkinsonian rats. Front Behav Neurosci 8:331","journal-title":"Front Behav Neurosci"},{"key":"4158_CR60","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1111\/j.1476-5381.2011.01567.x","volume":"165","author":"T Renoir","year":"2012","unstructured":"Renoir T, Pang TY, Zajac MS, Chan G, Du X, Leang L, Chevarin C, Lanfumey L, Hannan AJ (2012) Treatment of depressive-like behaviour in Huntington\u2019s disease mice by chronic sertraline and exercise. Br J Pharmacol 165:1375\u20131389","journal-title":"Br J Pharmacol"},{"key":"4158_CR61","doi-asserted-by":"publisher","first-page":"1189957","DOI":"10.3389\/fphar.2023.1189957","volume":"14","author":"PT Lum","year":"2023","unstructured":"Lum PT, Sekar M, Seow LJ, Shaikh MF, Arulsamy A, Retinasamy T, Gan SH, Gnanaraj C, Esa NM, Ramachawolran G, Subramaniyan V, Chinni SV, Wu YS (2023) Neuroprotective potency of mangiferin against 3-nitropropionic acid induced Huntington\u2019s disease-like symptoms in rats: possible antioxidant and anti-inflammatory mechanisms. Front Pharmacol 14:1189957","journal-title":"Front Pharmacol"},{"key":"4158_CR62","doi-asserted-by":"crossref","unstructured":"Spijker S (2011) Dissection of rodent brain regions. Neuroproteomics:13\u201326","DOI":"10.1007\/978-1-61779-111-6_2"},{"key":"4158_CR63","doi-asserted-by":"publisher","first-page":"e955","DOI":"10.21769\/BioProtoc.955","volume":"3","author":"FA Sultan","year":"2013","unstructured":"Sultan FA (2013) Dissection of different areas from mouse Hippocampus. Bio Protoc 3:e955\u2013e955","journal-title":"Bio Protoc"},{"key":"4158_CR64","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/S0021-9258(19)52451-6","volume":"193","author":"OH Lowry","year":"1951","unstructured":"Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193:265\u2013275","journal-title":"J Biol Chem"},{"key":"4158_CR65","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1042\/bj0990667","volume":"99","author":"ED Wills","year":"1966","unstructured":"Wills ED (1966) Mechanisms of lipid peroxide formation in animal tissues. Biochem J 99:667\u2013676","journal-title":"Biochem J"},{"key":"4158_CR66","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/S0076-6879(84)05016-3","volume":"105","author":"H Aebi","year":"1984","unstructured":"Aebi H (1984) Catalase in vitro. Methods Enzymol 105:121\u2013126","journal-title":"Methods Enzymol"},{"key":"4158_CR67","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1046\/j.1471-4159.1999.0731127.x","volume":"73","author":"SB Berman","year":"1999","unstructured":"Berman SB, Hastings TG (1999) Dopamine oxidation alters mitochondrial respiration and induces permeability transition in brain mitochondria: implications for Parkinson\u2019s disease. J Neurochem 73:1127\u20131137","journal-title":"J Neurochem"},{"key":"4158_CR68","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1038\/nprot.2012.058","volume":"7","author":"M Spinazzi","year":"2012","unstructured":"Spinazzi M, Casarin A, Pertegato V, Salviati L, Angelini C (2012) Assessment of mitochondrial respiratory chain enzymatic activities on tissues and cultured cells. Nat Protoc 7:1235\u20131246","journal-title":"Nat Protoc"},{"key":"4158_CR69","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1016\/0006-3002(58)90487-6","volume":"28","author":"H Tedeschi","year":"1958","unstructured":"Tedeschi H, Harris DL (1958) Some observations on the photometric estimation of mitochondrial volume. Biochim Biophys Acta 28:392\u2013402","journal-title":"Biochim Biophys Acta"},{"key":"4158_CR70","doi-asserted-by":"publisher","first-page":"660","DOI":"10.2174\/0115672050286225231230130613","volume":"20","author":"S Tyagi","year":"2023","unstructured":"Tyagi S, Thakur AK (2023) Neuropharmacological study on Capsaicin in Scopolamine-injected mice. Curr Alzheimer Res 20:660\u2013676","journal-title":"Curr Alzheimer Res"},{"key":"4158_CR71","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1016\/j.biopha.2016.09.070","volume":"84","author":"S Thangarajan","year":"2016","unstructured":"Thangarajan S, Ramachandran S, Krishnamurthy P (2016) Chrysin exerts neuroprotective effects against 3-Nitropropionic acid induced behavioral despair-mitochondrial dysfunction and striatal apoptosis via upregulating Bcl-2 gene and downregulating bax-bad genes in male wistar rats. Biomed Pharmacother 84:514\u2013525","journal-title":"Biomed Pharmacother"},{"key":"4158_CR72","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1016\/0197-0186(94)90096-5","volume":"24","author":"P Froissard","year":"1994","unstructured":"Froissard P, Duval D (1994) Cytotoxic effects of glutamic acid on PC12 cells. Neurochem Int 24:485\u2013493","journal-title":"Neurochem Int"},{"key":"4158_CR73","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1006\/bbrc.1995.2647","volume":"216","author":"C Behl","year":"1995","unstructured":"Behl C, Widmann M, Trapp T, Holsboer F (1995) 17-beta estradiol protects neurons from oxidative stress-induced cell death in vitro. Biochem Biophys Res Commun 216:473\u2013482","journal-title":"Biochem Biophys Res Commun"},{"key":"4158_CR74","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s12276-018-0111-4","volume":"50","author":"E Bok","year":"2018","unstructured":"Bok E, Chung YC, Kim KS, Baik HH, Shin WH, Jin BK (2018) Modulation of M1\/M2 polarization by capsaicin contributes to the survival of dopaminergic neurons in the lipopolysaccharide-lesioned substantia nigra in vivo. Exp Mol Med 50:1\u201314","journal-title":"Exp Mol Med"},{"key":"4158_CR75","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1016\/S0306-4522(97)00078-X","volume":"80","author":"MP Flavin","year":"1997","unstructured":"Flavin MP, Coughlin K, Ho LT (1997) Soluble macrophage factors trigger apoptosis in cultured hippocampal neurons. Neuroscience 80:437\u2013448","journal-title":"Neuroscience"},{"key":"4158_CR76","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1083\/jcb.141.6.1423","volume":"141","author":"S Tan","year":"1998","unstructured":"Tan S, Sagara Y, Liu Y, Maher P, Schubert D (1998) The regulation of reactive oxygen species production during programmed cell death. J Cell Biol 141:1423\u20131432","journal-title":"J Cell Biol"},{"key":"4158_CR77","doi-asserted-by":"publisher","first-page":"497","DOI":"10.2174\/1568026013394741","volume":"1","author":"S Tan","year":"2001","unstructured":"Tan S, Schubert D, Maher P (2001) Oxytosis: a novel form of programmed cell death. Curr Top Med Chem 1:497\u2013506","journal-title":"Curr Top Med Chem"},{"key":"4158_CR78","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1097\/00008877-200609000-00014","volume":"17","author":"P Kumar","year":"2006","unstructured":"Kumar P, Padi SSV, Naidu PS, Kumar A (2006) Effect of resveratrol on 3-nitropropionic acid-induced biochemical and behavioural changes: possible neuroprotective mechanisms. Behav Pharmacol 17:485\u2013492","journal-title":"Behav Pharmacol"},{"key":"4158_CR79","first-page":"5161","volume":"254","author":"C Cole","year":"1979","unstructured":"Cole C, Edmondson D, Singer T (1979) Inactivation of succinate dehydrogenase by 3-nitropropionic acid. J BiolChem 254:5161\u20135167","journal-title":"J BiolChem"},{"key":"4158_CR80","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/0041-0101(94)00173-6","volume":"33","author":"Y-T Fu","year":"1995","unstructured":"Fu Y-T, He F-S, Zhang S-L, Zhang J-S (1995) Lipid peroxidation in rats intoxicated with 3-nitropropionic acid. Toxicon 33:327\u2013331","journal-title":"Toxicon"},{"key":"4158_CR81","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/0006-2952(86)90544-7","volume":"35","author":"H Kappus","year":"1986","unstructured":"Kappus H (1986) Overview of enzyme systems involved in bioreduction of drugs and in redox cycling. Biochem Pharmacol 35:1\u20136","journal-title":"Biochem Pharmacol"},{"key":"4158_CR82","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1007\/s13596-016-0237-7","volume":"16","author":"JO Bhangale","year":"2016","unstructured":"Bhangale JO, Acharya NS, Acharya SR (2016) Protective effect of Ficus religiosa (L.) against 3-nitropropionic acid induced Huntington disease. Orient Pharm Exp Med 16:165\u2013174","journal-title":"Orient Pharm Exp Med"},{"key":"4158_CR83","doi-asserted-by":"publisher","first-page":"1758","DOI":"10.1007\/s11064-015-1658-2","volume":"40","author":"S Singh","year":"2015","unstructured":"Singh S, Jamwal S, Kumar P (2015) Piperine enhances the Protective Effect of Curcumin against 3-NP Induced Neurotoxicity: possible neurotransmitters modulation mechanism. Neurochem Res 40:1758\u20131766","journal-title":"Neurochem Res"},{"key":"4158_CR84","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.brainres.2003.09.049","volume":"994","author":"JA Saydoff","year":"2003","unstructured":"Saydoff JA, Liu LS, Garcia RA, Hu Z, Li D, von Borstel RW (2003) Oral uridine pro-drug PN401 decreases neurodegeneration, behavioral impairment, weight loss and mortality in the 3-nitropropionic acid mitochondrial toxin model of Huntington\u2019s disease. Brain Res 994:44\u201354","journal-title":"Brain Res"},{"key":"4158_CR85","doi-asserted-by":"publisher","first-page":"4181","DOI":"10.1523\/JNEUROSCI.13-10-04181.1993","volume":"13","author":"MF Beal","year":"1993","unstructured":"Beal MF, Brouillet E, Jenkins BG, Ferrante RJ, Kowall NW, Miller JM, Storey E, Srivastava R, Rosen BR, Hyman BT (1993) Neurochemical and histologic characterization of striatal excitotoxic lesions produced by the mitochondrial toxin 3-nitropropionic acid. J Neurosci 13:4181\u20134192","journal-title":"J Neurosci"},{"key":"4158_CR86","doi-asserted-by":"publisher","first-page":"1709","DOI":"10.1046\/j.1471-4159.2000.0751709.x","volume":"75","author":"MAL Fontaine","year":"2000","unstructured":"Fontaine MAL, Geddes JW, Banks A, Butterfield DA (2000) Effect of exogenous and endogenous antioxidants on 3-Nitropionic Acid\u2010inducedin vivo oxidative stress and striatal lesions: insights into Huntington\u2019s Disease. J Neurochem 75:1709\u20131715","journal-title":"J Neurochem"},{"key":"4158_CR87","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/S0140-6736(07)60111-1","volume":"369","author":"FO Walker","year":"2007","unstructured":"Walker FO (2007) Huntington\u2019s disease. Lancet 369:218\u2013228","journal-title":"Lancet"},{"key":"4158_CR88","doi-asserted-by":"publisher","first-page":"673","DOI":"10.3109\/00207454.2013.872642","volume":"124","author":"S Thangarajan","year":"2014","unstructured":"Thangarajan S, Deivasigamani A, Natarajan SS, Krishnan P, Mohanan SK (2014) Neuroprotective activity of L-theanine on 3-nitropropionic acid-induced neurotoxicity in rat striatum. Int J Neurosci 124:673\u2013684","journal-title":"Int J Neurosci"},{"key":"4158_CR89","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.molbrainres.2004.10.033","volume":"133","author":"BS Mandavilli","year":"2005","unstructured":"Mandavilli BS, Boldogh I, Van Houten B (2005) 3-nitropropionic acid-induced hydrogen peroxide, mitochondrial DNA damage, and cell death are attenuated by Bcl-2 overexpression in PC12 cells. Mol Brain Res 133:215\u2013223","journal-title":"Mol Brain Res"},{"key":"4158_CR90","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.neures.2006.04.018","volume":"56","author":"MN Herrera-Mundo","year":"2006","unstructured":"Herrera-Mundo MN, Silva-Adaya D, Maldonado PD, Galvan-Arzate S, Andres-Martinez L, Perez-De La Cruz V, Pedraza-Chaverri J, Santamaria A (2006) S-Allylcysteine prevents the rat from 3-nitropropionic acid-induced hyperactivity, early markers of oxidative stress and mitochondrial dysfunction. Neurosci Res 56:39\u201344","journal-title":"Neurosci Res"},{"key":"4158_CR91","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1111\/j.1750-3639.1999.tb00216.x","volume":"9","author":"SE Browne","year":"1999","unstructured":"Browne SE, Ferrante RJ, Beal MF (1999) Oxidative stress in Huntington\u2019s disease. Brain Pathol 9:147\u2013163","journal-title":"Brain Pathol"},{"key":"4158_CR92","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.ejphar.2004.02.004","volume":"488","author":"P Montilla","year":"2004","unstructured":"Montilla P, Tunez I, Munoz MC, Salcedo M, Feijoo M, Munoz-Castaneda JR, Bujalance I (2004) Effect of glucocorticoids on 3-nitropropionic acid-induced oxidative stress in synaptosomes. Eur J Pharmacol 488:19\u201325","journal-title":"Eur J Pharmacol"},{"key":"4158_CR93","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1016\/j.lfs.2006.12.013","volume":"80","author":"I Tunez","year":"2007","unstructured":"Tunez I, Feijoo M, Collado JA, Medina FJ, Pena J, Munoz Mdel C, Jimena I, Franco F, Rueda I, Muntane J, Montilla P (2007) Effect of testosterone on oxidative stress and cell damage induced by 3-nitropropionic acid in striatum of ovariectomized rats. Life Sci 80:1221\u20131227","journal-title":"Life Sci"},{"key":"4158_CR94","doi-asserted-by":"publisher","first-page":"15005","DOI":"10.1038\/nrdp.2015.5","volume":"1","author":"GP Bates","year":"2015","unstructured":"Bates GP, Dorsey R, Gusella JF, Hayden MR, Kay C, Leavitt BR, Nance M, Ross CA, Scahill RI, Wetzel R, Wild EJ, Tabrizi SJ (2015) Huntington disease. Nat Reviews Disease Primers 1:15005","journal-title":"Nat Reviews Disease Primers"},{"key":"4158_CR95","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1007\/s00441-018-02980-x","volume":"376","author":"A Aliaghaei","year":"2019","unstructured":"Aliaghaei A, Boroujeni ME, Ahmadi H, Bayat AH, Tavirani MR, Abdollahifar MA, Pooyafar MH, Mansouri V (2019) Dental pulp stem cell transplantation ameliorates motor function and prevents cerebellar atrophy in rat model of cerebellar ataxia. Cell Tissue Res 376:179\u2013187","journal-title":"Cell Tissue Res"},{"key":"4158_CR96","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.neuroscience.2014.12.018","volume":"287","author":"A Khan","year":"2015","unstructured":"Khan A, Jamwal S, Bijjem KR, Prakash A, Kumar P (2015) Neuroprotective effect of hemeoxygenase-1\/glycogen synthase kinase-3beta modulators in 3-nitropropionic acid-induced neurotoxicity in rats. Neuroscience 287:66\u201377","journal-title":"Neuroscience"},{"key":"4158_CR97","doi-asserted-by":"publisher","first-page":"258","DOI":"10.3389\/fnmol.2019.00258","volume":"12","author":"TH Palpagama","year":"2019","unstructured":"Palpagama TH, Waldvogel HJ, Faull RLM, Kwakowsky A (2019) The role of microglia and astrocytes in Huntington\u2019s Disease. Front Mol Neurosci 12:258","journal-title":"Front Mol Neurosci"},{"key":"4158_CR98","doi-asserted-by":"publisher","first-page":"147","DOI":"10.15406\/japlr.2021.10.00378","volume":"10","author":"R Kumari","year":"2021","unstructured":"Kumari R, Shekhar N, Tyagi S, Thakur A (2021) Mitochondrial dysfunctions and neurodegenerative diseases: a mini-review. J Anal Pharm Res 10:147\u2013149","journal-title":"J Anal Pharm Res"},{"key":"4158_CR99","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1038\/nature08983","volume":"464","author":"NA Bishop","year":"2010","unstructured":"Bishop NA, Lu T, Yankner BA (2010) Neural mechanisms of ageing and cognitive decline. Nature 464:529\u2013535","journal-title":"Nature"},{"key":"4158_CR100","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/S0168-0102(98)00055-8","volume":"31","author":"K Abe","year":"1998","unstructured":"Abe K, Saito H (1998) Amyloid beta protein inhibits cellular MTT reduction not by suppression of mitochondrial succinate dehydrogenase but by acceleration of MTT formazan exocytosis in cultured rat cortical astrocytes. Neurosci Res 31:295\u2013305","journal-title":"Neurosci Res"},{"key":"4158_CR101","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1016\/j.neuint.2010.07.005","volume":"57","author":"R Sandhir","year":"2010","unstructured":"Sandhir R, Mehrotra A, Kamboj SS (2010) Lycopene prevents 3-nitropropionic acid-induced mitochondrial oxidative stress and dysfunctions in nervous system. Neurochem Int 57:579\u2013587","journal-title":"Neurochem Int"}],"container-title":["Neurochemical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11064-024-04158-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11064-024-04158-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11064-024-04158-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,10]],"date-time":"2024-07-10T04:08:30Z","timestamp":1720584510000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11064-024-04158-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,30]]},"references-count":101,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2024,8]]}},"alternative-id":["4158"],"URL":"https:\/\/doi.org\/10.1007\/s11064-024-04158-0","relation":{},"ISSN":["0364-3190","1573-6903"],"issn-type":[{"value":"0364-3190","type":"print"},{"value":"1573-6903","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,30]]},"assertion":[{"value":"3 April 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 May 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 May 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 May 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors confirm that this article\u2019s content has no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}